Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_assertion description "[Moreover, dominant negative cross talk between ectopic wild-type p53 and recently identified dominant p53 mutants and splice variants of p63 and p73--which are frequently overexpressed in ovarian cancers--could seriously compromise the effectiveness of p53 gene therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_assertion evidence source_evidence_literature NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_assertion SIO_000772 12850192 NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_assertion wasDerivedFrom befree-20150227 NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_assertion wasGeneratedBy ECO_0000203 NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP799826.RACQohRI8PZvi1UxE0xR3rJ36dgL2z_xvb0fT3Y-yrHyc130_provenance.